Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.925
Bid: 18.40
Ask: 19.45
Change: -0.275 (-1.43%)
Spread: 1.05 (5.707%)
Open: 19.20
High: 0.00
Low: 0.00
Prev. Close: 19.20
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

6 Oct 2022 07:00

RNS Number : 9495B
BATM Advanced Communications Ld
06 October 2022
 

LEI: 213800FLQUB9J289RU66

6 October 2022

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Directorate Changes

 

The Board of BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that Moti Nagar, the Group's Chief Financial Officer, is to be promoted to become its Chief Executive Officer effective from 1 January 2023. Zvi Marom, its current Chief Executive Officer, is to step down on 1 January 2023, but will remain on the Board as Non-Executive Director.

 

Mr. Nagar has been the Group's Chief Financial Officer since 1 January 2015 having joined BATM in June 2014 as VP Finance. Over the past three years, in addition to being the CFO, Mr. Nagar has been the de facto Chief Operating Officer of the Group, supporting Dr. Marom in the running of day-to-day operations. Prior to BATM, Mr. Nagar held several senior positions at Deloitte from 2005, including as a Senior Manager from 2011-2014. During that time, Mr. Nagar had various responsibilities, including handling the accounts of leading corporate clients in Israel and overseas, with companies traded on the LSE, NASDAQ and TASE, as well as private businesses operating in a range of sectors.

 

Dr. Gideon Chitayat, Chairman of Board, said: "On behalf of the Board, I would like to thank Zvi for his tireless commitment and outstanding contribution to the development and success of BATM since founding it in 1992. Under his leadership, the team at BATM has delivered exceptional value creation for shareholders during those years. He passes on BATM in a strong financial position and with a solid platform to push ahead with the commercialisation of the IP developed within the Group. We look forward to benefitting from his continued contribution as a Board member.

 

"It is a measure of our reputation as a business that we are able to attract and retain high-quality people and I am delighted that Moti has agreed to become our Chief Executive Officer. Moti brings his sound financial knowledge to this position and, coupled with his capital markets and M&A expertise, I am sure he will help shape the future of BATM as a global company. Most importantly, having helped in running the day-to-day operations over the past three years, he not only provides continuity but has impressed the Board with exciting ideas on how to take the Group to the next level. We look forward to working with him in this new role and leveraging his extensive experience."  

 

Dr. Zvi Marom, Chief Executive Officer of BATM, commented: "It has been a privilege to serve as Chief Executive Officer of BATM. Since I founded the business 30 years ago, I have truly enjoyed working with our incredible teams and I would like to take this opportunity to thank my colleagues with whom I have had the pleasure of working and who have provided so much inspiration. I am incredibly proud of what we have achieved together.

 

"With both the Networking & Cyber and Bio-medical divisions at key inflection points, I feel now is the natural moment for me to hand over the running of the Group to someone who can progress it to the next stage. It gives me great confidence to welcome Moti as my successor. Moti has the necessary pedigree and is highly respected by the people in the Group and our shareholders. He has my full support as the right person to take BATM forward on the next leg of its exciting journey. In my new role, I will make myself available to ensure smooth transition and help wherever I can to enable BATM to go from strength to strength."

 

Moti Nagar, Incoming Chief Executive Officer of BATM, said: "I am delighted to take on the role of Chief Executive Officer of BATM. Under the leadership of Zvi, the remarkable progress over the past few years has created a strong platform for future growth. I look forward to working closely with the Board, the BATM team and our key partners as we continue to drive forward a multi-pronged growth strategy and realise further value for shareholders."

 

 

Enquiries:

 

BATM Advanced Communications

Dr. Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

 

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMGGRKLGZZM
Date   Source Headline
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.